Hookipa Biotech

Latest Headlines

Latest Headlines

Therapeutic vaccine upstart Hookipa snags $27M round to fund PhI move

A pair of prominent pharma players are partnering up with a few marquee European VCs to back an up-and-coming immunotherapy biotech based in Vienna.

Vaccine startup banks $10M round for Ph1 study

A startup biotech company focused on a new generation of vaccines has brought in more than $10 million in Series A cash, with Paris-based Sofinnova Partners joining with Forbion Capital Partners on